Medicure, Inc. (NASDAQ:MCUJF)

BRIEF

published on 05/21/2026 at 23:05, 1 hour 54 minutes ago

Medicure Posts Improved Q1 2026 Financial Results, Faces Challenges

Financial Results Medicure AGGRASTAT® ZYPITAMAG® Pharmacy Acquisitions
PRESS RELEASE

published on 05/21/2026 at 23:00, 1 hour 59 minutes ago

Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Medicure Inc. reports Q1 2026 financial results: Total net revenue increased, highlighting revenue sources; EBITDA improved; net loss decreased. Key acquisitions and R&D investments noted

Financial Results Medicure Inc. R&D Investments Q1 2026 Revenue Sources
BRIEF

published on 04/24/2026 at 00:20, 28 days ago

Medicure's 2025 Financial Results Indicate Revenue Growth Amid Losses

Financial Results Net Revenue AGGRASTAT R&D Expenses Pharmacy Segment
PRESS RELEASE

published on 04/24/2026 at 00:15, 28 days ago

Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
Medicure Inc. reports financial results for the year ended December 31, 2025, with total net revenue of $28.9 million and plans a conference call on April 27, 2026 at 8:30 am Eastern Time

Financial Results Conference Call Pharmaceuticals Medicure Inc. Net Revenue
BRIEF

published on 04/18/2026 at 01:40, 1 month 3 days ago

Medicure Announces Leadership Change

Pharmaceuticals Strategic Priorities Medicure Inc. Leadership Change United States Market
PRESS RELEASE

published on 04/18/2026 at 01:35, 1 month 3 days ago

Medicure Announces Resignation of President and Chief Operating Officer
Medicure Inc. announces resignation of President and COO, Dr. Neil Owens. CEO Dr. Albert D. Friesen to assume responsibilities. Company remains focused on strategic priorities for the future

Pharmaceuticals Resignation Healthcare Medicure Inc. Leadership
BRIEF

published on 11/19/2025 at 23:05, 6 months 2 days ago

Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss

Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE

published on 11/19/2025 at 23:00, 6 months 2 days ago

Medicure Reports Financial Results for Quarter Ended September 30, 2025
Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights

Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF

published on 11/13/2025 at 23:35, 6 months 8 days ago

Medicure to Announce Q3 2025 Financial Results on November 20

Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE

published on 11/13/2025 at 23:30, 6 months 8 days ago

Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market

Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products

1 2 ... 6

Published on 05/22/2026 at 00:45, 14 minutes ago

Credissential Announces Private Placement
Published on 05/21/2026 at 23:00, 1 hour 59 minutes ago

Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 1 hour 59 minutes ago

Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 1 hour 59 minutes ago

Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 2 hours 44 minutes ago

Linear Announces Acquisition, Share Consolidation and Private Placement

View all ACCESSWIRE

Published on 05/21/2026 at 21:45, 3 hours 14 minutes ago

Rendeavour becomes the African Continental Free Trade Area's inaugural implementation partner for African industrialisation and trade infrastructure
Published on 05/21/2026 at 20:10, 4 hours 49 minutes ago

Ernst Russ AG Divests MV 'EF Emira' and Raises Full-Year 2026 Guidance
Published on 05/21/2026 at 20:05, 4 hours 54 minutes ago

EQS-Adhoc: Ernst Russ AG: Upward revision of the guidance for the financial year 2026
Published on 05/21/2026 at 20:00, 4 hours 59 minutes ago

VINFAST INTRODUCES THE NEW-GENERATION VF 8, FEATURING COMPREHENSIVE ENHANCEMENTS
Published on 05/21/2026 at 18:26, 6 hours 33 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS

Published on 05/21/2026 at 17:50, 7 hours 9 minutes ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 7 hours 14 minutes ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 07:30, 17 hours 29 minutes ago

Biophytis participates in the first Longevity Summit
Published on 05/20/2026 at 18:00, 1 day 6 hours ago

General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 17:45, 1 day 7 hours ago

Report on share repurchases from 13 to 19 May 2026

View all LES ECHOS COMFI WIRE

News